AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus

Kidney International

Volumn 54, Issue 6, 1998, Pages 1909-1922

  Wildin, Robert S ^a   Cogdell, David E ^a   Valadez, Victoria ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aquaporin 2; Arginine vasopressin; Congenital nephrogenic diabetes insipidus; G protein coupled receptors; Gene mutations; Genetic testing; Protein structure; Signal transduction; Water homeostasis

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; DNA; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; OXYTOCIN RECEPTOR; VASOPRESSIN V2 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CARCINOMA CELL; CHILD; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; MISSENSE MUTATION; NEPHROGENIC DIABETES INSIPIDUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0031756461     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00214.x     Document Type: Article

References (51)

1. LOLAIT SJ, O'CARROLL AM, MCBRIDE OW, KONIG M, MOREL A, BROWNSTEIN MJ: Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339, 1992
2. LUZIUS H, JANS DA, GRUNBAUM EG, MORITZ A, RASCHER W, FAHRENHOLZ F: A low affinity vasopressin V2-receptor in inherited nephrogenic diabetes insipidus. J Receptor Res 12:351-368, 1992
3. PAN Y, METZENBERG A, DAS S, JING B, GITSCHIER J: Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nature Genet 2:103-106, 1992
4. ROSENTHAL W, SEIBOLD A, ANTARAMIAN A, LONERGAN M, ARTHUS MF, HENDY GN, BIRNBAUMER M, BICHET DG: Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233-235, 1992
5. VAN DEN OUWELAND AM, DREESEN JC, VERDIJK M, KNOERS NV, MONNENS LA, ROCCHI M, VAN OOST BA: Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nature Genet 2:99-102, 1992
6. CANFIELD MC, TAMARAPPOO BK, MOSES AM, VERKMAN AS, HOLTZMAN EJ: Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet 6:1865-1871, 1997
7. DEEN PM, VERDIJK MA, KNOERS NV, WIERINGA B, MONNENS LA, VAN OS CH, VAN OOST BA: Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264:92-95, 1994
8. HOCHBERG Z, VAN LIEBURG A, EVEN L, BRENNER B, LANIR N, VAN OOST BA, KNOERS NV: Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab 82:686-689, 1997
9. OKSCHE A, MOLLER A, DICKSON J, ROSENDAHL W, RASCHER W, BICHET DG, ROSENTHAL W: Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Hum Genet 98:587-589, 1996
10. VAN LIEBURG AF, VERDIJK MA, KNOERS W, VAN ESSEN AJ, PROESMANS W, MALLMANN R, MONNENS LA, VAN OOST BA, VAN OS CH, DEEN PM: Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55:648-652, 1994
11. VARGAS-POUSSOU R, FORESTIER L, DAUTZENBERG MD, NIAUDET P, DECHAUX M, ANTIGNAC C: Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 8:1855-1862, 1997
12. HEDIN KE, DUERSON K, CLAPHAM ED: Specificity of receptor-G protein interactions: Searching for the structure behind the signal. Cell Signal 5:505-518, 1993
13. WILDIN RS, ANTUSH MJ, BENNETT RL, SCHOOF JM, SCOTT CR: Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet 55:266-277, 1994
14. SAMBROOK J, FRITSCH E, MANIATIS T: Molecular Cloning: A Laboratory Manual (2nd ed). Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989
15. BONNER TI, YOUNG AC, BRANN MR, BUCKLEY NJ: Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1:403-410, 1988
16. MELLON P, PARKER V, GLUZMAN Y, MANIATIS T: Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell 27:279-288, 1981
17. MELLON PL, CLEGG CH, CORRELL LA, MCKNIGHT GS: Regulation of transcription by cyclic AMP-dependent protein kinase. Proc Natl Acad Sci USA 86:4887-4891, 1989
18. EDLUND T, WALKER MD, BARR PJ, RUTTER WJ: Cell-specific expression of the rat insulin gene: Evidence for role of two distinct 5′ flanking elements. Science 230:912-916, 1985
19. MIGEON JC, THOMAS SL, NATHANSON NM: Differential coupling of m2 and m4 muscarinic receptors to inhibition of anenylyl cyclase by Gi-alpha and Go-alpha subunits. J Biol Chem 270:16070-16074, 1995
20. GLANTZ SA: Primer of Biostatistics. San Francisco, McGraw-Hill, 1981, p 352
21. MIGEON J, NATHANSON N: Differential regulation of cAMP-mediated gene transcription by ml and m4 muscarinic acetylcholine receptors. J Biol Chem 269:9767-9773, 1994
22. BASSETT DJ: Genome cross-referencing and XREFdb: Implications for the identification and analysis of genes mutated in human disease. Nature Genet 15:339-344, 1997
23. HOLTZMAN EJ, KOLAKOWSKI LF JR, O'BRIEN D, CRAWFORD JD, AUSIELLO DA: A Null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred. Hum Molec Genet 2:1201-1204, 1993
24. BODE HH, CRAWFORD JD: Nephrogenic diabetes insipidus in North America - The Hopewell hypothesis. N Engl J Med 280:750-754, 1969
25. VOGEL F, MOTULSKY AG: Human Genetics: Problems and Approaches (3rd ed). Berlin, Springer, 1997, p 851
26. WILDIN R, COGDELL D: The clinical utility of direct mutation testing for congenital nephrogenic diabetes insipidus. Pediatrics (in press)
27. NOMURA Y, ONIGATA K, NAGASHIMA T, YUTANI S, MOCHIZUKI H, NAGASHIMA K, MORIKAWA A: Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 82:3434-3437, 1997
28. VAN LIEBURG AF, VERDIJK MA, SCHOUTE F, LIGTENBERG, MJ, VAN OOST BA, WALDHAUSER F, DOBNER M, MONNENS LA, KNOERS NV: Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 96:70-78, 1995
29. RHEE AMV, JACOBSON KA: Molecular architecture of G protein-coupled receptors. Drug Devel Res 37:1-38, 1996
30. YOKOYAMA K, YAMAUCHI A, IZUMI M, ITOH T, ANDO A, IMAI E, KAMADA T, UEDA N: A low-affinity vasopressin V2-reccptor gene in a kindred with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 7:410-414, 1996
31. JAVITCH JA, FU D. CHEN J: Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding site crevice. Biochem 34:16433-16439, 1995
32. KOJRO E, EICH P, GIMPI G, FARENHOLZ F: Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. Biochemistry 32:13537-13544, 1993
33. BIRNBAUMER M, GILBERT S, ROSENTHAL W: An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system. Molec Endocrinol 8:886-894, 1994
34. DIXON RAF, SIGAL IS, STRADER CD: Structure-function analysis of the beta-adrenergic receptor. Cold Spring Harbor Symp Quant Biol LIII:487-497, 1988
35. STRADER CD, SIGAL IS, REGISTER RB, CANDELORE MR, RANDS E, DIXON RAF: Identification of residues required for ligand binding to the Beta-adrenergic receptor. Proc Natl Acad Sci USA 84:4384-4388, 1987
36. BICHET DG, BIRNBAUMER M, LONERGAN M, ARTHUS MF, ROSENTHAL W, GOODYER P, NIVET H, BENOIT S, GIAMPIETRO P, SIMONETTI S, FISH A, WHITLEY CB, JAEGER P, GEIRTNER J, NEW M, DI BONA FJ, KAPLAN BS, ROBERTSON GL, HENDY GN, FUJIWARA TM, MORGAN K: Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55:278-286, 1994
37. KNOERS NV, VAN DEN OUWELAND AM, VERDIJK M, MONNENS LA, VAN OOST BA: Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 46:170-176, 1994
38. PAN Y, WILSON P, GITSCHIER J: The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J Biol Chem 269:31933-31937, 1994
39. WENKERT D, MERENDINO JJ JR, SHENKER A, THAMBI N, ROBERTSON GL, MOSES AM, SPIEGEL AM: Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum Molec Genet 3:1429-1430, 1994
40. WENKERT D, SCHONEBERG T, MERENDINO JJ JR, RODRIGUEZ PENA MS, VINITSKY R, GOLDSMITH PK, WESS J, SPIEGEL AM: Functional characterization of five V2 vasopressin receptor gene mutations. Mol Cell Endocrinol 124:43-50, 1996
41. SCHONEBERG T, YUN J, WENKERT D, WESS J: Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 15:1283-1291, 1996
42. OKSCHE A, SCHULEIN R, RUTZ C, LIEBENHOFF U, DICKSON J. MULLER H, BIRNBAUMER M, ROSENTHAL W: Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: Analysis of expression, processing, and function. Molec Pharmacol 50:820-828, 1996
43. CHEONG HI, PARK HW, HA IS, MOON HN, CHOI Y, KO KW, JUN JK: Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Nephron 75:431-437, 1997
44. FAA V, VENTRUTO ML, LOCHE S, BOZZOLA M, PODDA R, CAO A, ROSATELLI MC: Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. Hum Molec Genet 3:1685-1686, 1994
45. ROSENTHAL W, SEIBOLD A, ANTARAMIAN A, GILBERT S, BIRNBAUMER M, BICHET DG, ARTHUS MF, LONERGAN M: Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant. Cell Molec Biol 40:429-436, 1994
46. OKSCHE A, DICKSON J, SCHULEIN R, SEYBERTH HW, MULLER M, RASCHER W, BIRNBAUMER M, ROSENTHAL W: Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus. Biochem Biophys Res Comm 205:552-557, 1994 [published erratum appears in Biochem Biophys Res Commun 207(3): 1059, 1995]
47. YUASA H, ITO M, OISO Y, KUROKAWA M, WATANABE T, ODA Y, ISHIZUKA T, TANI N, ITO S, SHIBATA A, SAITO H: Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metahol 79:361-365, 1994
48. BICHET DG, ARTHUS MF, LONERGAN M, HENDY GN, PARADIS AJ, FUJIWARA TM, MORGAN K, GREGORY MC, ROSENTHAL W, DIDWANIA A, ANTARAMIAN A, BIRNBAUMER M: X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 92:1262-1268, 1993
49. TSUKAGUCHI H, MATSUBARA H, ARITAKI S, KIMURA T, ABE S, INADA M: Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Comm 197:1000-1010, 1993
50. SHOJI Y, TAKAHASHI T, SUZUKI Y, SUZUKI T, KOMATSU K, HIRONO H, SHOJI Y, YOKOYAMA T, KITO H, TAKADA G: Mutational analyses of AVPR2 gene in three Japanese families with X-linked nephrogenic diabetes insipidus: Two recurrent mutations, R137H and deltaV278, caused by the hypermutability at CpG dinucleotides. Hum Mutat Suppl 1:S278-S283, 1998
51. TAJIMA T, NAKAE J, TAKEKOSHI Y, TAKAHASHI Y, YURI K, NAGASHIMA T, FUJIEDA K: Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res 39:522-526, 1996